Show notes
This week on The Genetics Podcast, Patrick is joined by Dr. Inigo Martincorena, Group Leader at the Wellcome Sanger Institute. They discuss the discovery of widespread cancer-driver mutations in normal tissue, the role of somatic mutations in autoimmune disease, new sequencing technologies transforming the field, and the therapeutic potential of targeting these mutations.Show Notes0:00 Intro to The Genetics Podcast00:59 Welcome to Inigo 01:46 How Inigo's eyelid skin study revealed widespread cancer-driver mutations07:14 Findings from a follow-up study on esophageal tissue10:02 How NanoSeq technology scaled somatic mutation research across tissues12:34 The thyroid study linking somatic mutations to autoimmune disease17:07 How escaped B cell clones evolve into polyclonal autoimmune disease20:21 Immune gene mutations occurring in healthy aging lymphocytes21:21 Why driver mutation clones in normal tissue rarely become cancer24:16 Two therapeutic paradigms for targeting somatic mutations in disease28:13 Examples of somatic rescue mutations in the colon, liver, and blood29:20 Why clonal selection only occurs in dividing cell types31:20 The field's remaining blind spots in mobile immune cells and rare samples33:46 How new single-cell sequencing will link genotype to phenotype36:03 What Inigo has learned from collaborating across Sanger's expertise38:09 Closing remarksFind out moreEyelid studyEsophagus study



